The development and performance of a radioimmunoassay for the analysis of ZM 213,689, the major metabolite of meropenem—a carbapenem antibiotic—in plasma and urine
- 29 February 1996
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 14 (4), 409-417
- https://doi.org/10.1016/0731-7085(95)01656-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1992
- Development of Specific Antisera against 9-Desglycinamide-8- Arginine Vasopressin by Site-Specific ImmunizationJournal of Pharmaceutical Sciences, 1991
- Meropenem: activity against resistant Gram-negative bacteria and interactions with -lactamasesJournal of Antimicrobial Chemotherapy, 1989
- Activity of meropenem, against Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1989
- The disposition and metabolism of meropenem in laboratory animals and manJournal of Antimicrobial Chemotherapy, 1989
- Radioimmunoassay of propranololAnalytical Chemistry, 1983
- Development and optimisation of a radioimmunoassay for plasma captoprilClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugatesBiochemistry, 1979
- Investigations into the choice of immunogen, ligand, antiserum and assay conditions for the radioimmunoassay of conjugated cholic acidClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Enzyme Coupled Immunoassay of Insulin Using a Novel Coupling ReagentThe Journal of Biochemistry, 1976